All Studies

Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.

Dioh W et al (2021).
Trials.
PubMed:
33430924

Pergularia daemia alters epileptogenesis and attenuates cognitive impairment in kainate-treated mice: Insight into anti-inflammatory mechanisms.

Researchers investigated the potential anti-inflammatory effects of Pergularia daemia in temporal lobe epilepsy, a drug-resistant form of epilepsy. P. daemia is traditionally used in Cameroon to treat various ailments. There are currently no scientific reports on its anti-inflammatory activity during epileptogenesis. The study found that P. daemia extract reduced inflammation and may have antiepileptic effects. This suggests that P. daemia could be a potential source of new antiepileptic drugs and warrants further investigation.

Kavaye Kandeda A et al (2021).
Epilepsy Behav.
PubMed:
33429138